March 2013

Janet Woodcock, Director of the Center for Drug Evaluation and Research (CDER) at the Food and Drug Administration (FDA) announced…

Two of the most recent settlements involving pharmaceutical companies alleged to have engaged in off-label promotion, included…

In December of last year, we reported on a landmark ruling from the United States Court of Appeals for the Second Circuit (New…

With increased focus on transparency and reporting or monitoring conflicts of interest (COI), there is more and more pressure on…

Eating lunches and feeling guilty is something we are supposed to do when we are older after we have gained some weight.   But now…

Earlier this month, New Jersey-based Par Pharmaceutical Companies Inc. (“Par”) pleaded guilty in federal court agreed to pay $45…

Over the past several years, there has been significant attention drawn the prescription drug abuse and overuse of painkillers or…

A recent article from Stamford Plus news in Connecticut discussed recently proposed legislation regarding continuing medical…

The Accreditation Council for Continuing Medical Education (ACCME) recently announced a new four-part video interview series that…

Federal law and regulations require Medicare Part D Pharmacy and Therapeutics (P&T) committees to make prescription drug…